PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 75 filers reported holding PASSAGE BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,052 | -32.2% | 240,200 | -3.0% | 0.00% | -100.0% |
| Q2 2023 | $233,160 | -21.6% | 247,700 | -20.2% | 0.00% | 0.0% |
| Q1 2023 | $297,366 | -51.0% | 310,500 | -29.4% | 0.00% | -50.0% |
| Q4 2022 | $607,338 | -4.7% | 440,100 | -13.6% | 0.00% | 0.0% |
| Q3 2022 | $637,000 | -53.5% | 509,200 | -12.4% | 0.00% | -50.0% |
| Q2 2022 | $1,371,000 | -15.6% | 581,000 | +10.8% | 0.00% | 0.0% |
| Q1 2022 | $1,625,000 | -40.6% | 524,300 | +21.6% | 0.00% | -42.9% |
| Q4 2021 | $2,737,000 | +73.3% | 431,000 | +171.9% | 0.01% | +75.0% |
| Q3 2021 | $1,579,000 | +276.0% | 158,500 | +400.0% | 0.00% | +300.0% |
| Q2 2021 | $420,000 | – | 31,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $49,399,000 | 20.45% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,185,869 | $11,811,000 | 9.97% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $24,879,000 | 7.18% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $49,892,000 | 3.99% |
| Orbimed Advisors | 6,962,899 | $69,350,000 | 0.76% |
| Boxer Capital, LLC | 1,928,315 | $19,206,000 | 0.67% |
| Vivo Capital, LLC | 539,263 | $5,371,000 | 0.24% |
| Logos Global Management LP | 125,010 | $1,245,000 | 0.09% |
| Weiss Multi-Strategy Advisers LLC | 336,034 | $3,347,000 | 0.07% |
| Virtus ETF Advisers LLC | 14,687 | $146,000 | 0.06% |